Chronic kidney disease and the risk of stroke: A systematic review and meta-analysis

Nephrology Dialysis Transplantation

Volumn 30, Issue 7, 2015, Pages 1162-1169

  Masson, Philip ^a   Webster, Angela C ^a,b   Hong, Martin ^c   Turner, Robin ^a   Lindley, Richard I ^c,d   Craig, Jonathan C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c University of Sydney   (Australia)

^d GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

Author keywords

albuminuria; chronic kidney disease; glomerular filtration rate; stroke; systematic review

Indexed keywords

ALBUMIN; CREATININE;

ALBUMINURIA; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; KIDNEY DYSFUNCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SYSTEMATIC REVIEW; ADULT; CARDIOVASCULAR DISEASES; CHRONIC KIDNEY FAILURE; COMPLICATION; META ANALYSIS; RISK FACTOR; STROKE;

ADULT; CARDIOVASCULAR DISEASES; COHORT STUDIES; HUMANS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; STROKE;

EID: 84936772843     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv009     Document Type: Article

References (31)

1. Wolfe CD. The impact of stroke. Br Med Bull 2000; 56: 275-286
2. Lozano R, Naghavi M, Foreman K et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-2128
3. Murphy SL, Xu J, Kochanek DK. Deaths: final data for 2010. National Vital Stat Rep 2013; 61: 1-117
4. Rosamond W, Flegal K, Furie K et al. Heart disease and stroke statistics- 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25
5. O'Hare AM. The management of elderly people with a low eGFR: moving toward an individualized approach. Am J Kidney Dis 2009; 53: 925
6. 2011 USRDS Annual Data Report. Chapter 6: Costs of Chronic Kidney Disease. United States Renal Data System website. http://www. usrds. org/2011/ view/v1-06. asp (1 February 2014, date last accessed)
7. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047
8. Go AS, Mozaffarian D, Roger VL et al. Heart disease and stroke statistics- 2013 update: a report from the American Heart Association. Circulation 2013; 127: e6
9. Lee M, Saver JL, Chang K-H et al. Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ 2010; 341: c4249
10. Ninomiya T, Perkovic V, Verdon C et al. Proteinuria and stroke: a metaanalysis of cohort studies. Am J Kidney Dis 2009; 53: 417-425
11. Higgins J, Altman DG. Assessing risk of bias in included studies. In: Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. The cochrane collaboration, 2008, pp. 187-241
12. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute website. http://www. ohri. ca/programs/clinical-epidemiology/oxford. asp (1 February 2014, date last accessed)
13. Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured? Ann Clin Biochem 2009; 46: 205-217
14. Levey AS, Coresh J, Balk E et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147
15. Lin J, Knight EL, HoganML et al. A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol 2003; 14: 2573-2580
16. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 1995; 4: 356-365
17. Di Angelantonio E, Danesh J, Eiriksdottir G et al. Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review. PLoS Med 2007; 4: e270
18. Perkovic V, Verdon C, Ninomiya T et al. The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS Med 2008; 5: e207
19. Holzmann M, Ivert T, Jungner I et al. Renal function assessed by two different formulas and incidence of myocardial infarction and death in middle? aged men and women. J Intern Med 2010; 267: 357-369
20. Matsushita K, van der Velde M, Astor BC et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081
21. Gansevoort RT, Matsushita K, van der VeldeM et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 2011; 80: 93-104
22. Hemmelgarn BR, Manns BJ, Lloyd A et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010; 303: 423-429
23. Holzmann MJ, Sartipy U. Relation between preoperative renal dysfunction and cardiovascular events (stroke, myocardial infarction, or heart failure or death) within three months of isolated coronary artery bypass grafting. Am J Cardiol 2013; 112: 1342-1346
24. Teo KK, Liu L, Chow CK et al. Potentially modifiable risk factors associated with myocardial infarction in China: the INTERHEART China study. Heart 2009; 95: 1857-1864
25. Misra A, Khurana L. Obesity-related non-communicable diseases: South Asians vs White Caucasians. Int J Obes 2011; 35: 167-187
26. Ramirez SPB, McClellanW, Port FK et al. Risk factors for proteinuria in a large, multiracial, southeast Asian population. J Am Soc Nephrol 2002; 13: 1907-1917
27. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease effects on the cardiovascular system. Circulation 2007; 116: 85-97
28. Moody WE, Edwards NC, Madhani M et al. Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: cause or association? Atherosclerosis 2012; 223: 86-94
29. Khan UA, Garg AX, Parikh CR et al. Prevention of chronic kidney disease and subsequent effect on mortality: a systematic review and meta-analysis. PLoS One 2013; 8: e71784
30. de Zeeuw D, Remuzzi G, Parving H-H et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004; 110: 921-927
31. Viberti G, Wheeldon NM. Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus a blood pressure-independent effect. Circulation 2002; 106: 672-678